Eton Pharmaceuticals, Inc.: cashflow_financing
| Value | {"amount": -295000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-06-30 |
| Status | superseded |
| Entity | Eton Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8076f1a6-775e-4cc2-8c0c-93bbf9c74ac6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-23-023067Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001710340/cashflow-financing/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8076f1a6-775e-4cc2-8c0c-93bbf9c74ac6
History
- no predecessors — first report